Higher cannabidiol plasma levels are associated with better seizure response following treatment with a pharmaceutical grade cannabidiol.

MLA

Szaflarski, Jerzy P., et al. “Higher Cannabidiol Plasma Levels Are Associated with Better Seizure Response Following Treatment with a Pharmaceutical Grade Cannabidiol.” Epilepsy & Behavior : E&B, vol. 95, June 2019, pp. 131–36. EBSCOhost, https://doi.org/10.1016/j.yebeh.2019.03.042.

APA

Szaflarski, J. P., Hernando, K., Bebin, E. M., Gaston, T. E., Grayson, L. E., Ampah, S. B., & Moreadith, R. (2019). Higher cannabidiol plasma levels are associated with better seizure response following treatment with a pharmaceutical grade cannabidiol. Epilepsy & Behavior : E&B, 95, 131–136. https://doi.org/10.1016/j.yebeh.2019.03.042

Chicago

Szaflarski, Jerzy P, Kathleen Hernando, E Martina Bebin, Tyler E Gaston, Leslie E Grayson, Steve B Ampah, and Randall Moreadith. 2019. “Higher Cannabidiol Plasma Levels Are Associated with Better Seizure Response Following Treatment with a Pharmaceutical Grade Cannabidiol.” Epilepsy & Behavior : E&B 95 (June): 131–36. doi:10.1016/j.yebeh.2019.03.042.